Novavax COVID-19 Vaccine Nuvaxovid(TM) Provisionally Registere...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., June 13, 2022 /PRNewswire-AsiaNet/ -- - In Australia, Nuvaxovid(TM) is the first protein-based COVID-19 vaccine registered for use as a booster regardless of previous vaccine historyNovavax, Inc. (NASDAQ: NVAX), a biotechnology company dedicated to developing and commercializing n...
Authors: LATEST ASIANET NEWS RELEASES